nodes	percent_of_prediction	percent_of_DWPC	metapath
Modafinil—Loose stools—Telbivudine—hepatitis B	0.0203	0.0236	CcSEcCtD
Modafinil—Cough increased—Adefovir Dipivoxil—hepatitis B	0.0146	0.017	CcSEcCtD
Modafinil—Musculoskeletal stiffness—Telbivudine—hepatitis B	0.0125	0.0146	CcSEcCtD
Modafinil—Neck pain—Telbivudine—hepatitis B	0.0114	0.0132	CcSEcCtD
Modafinil—Suicide attempt—Lamivudine—hepatitis B	0.0112	0.013	CcSEcCtD
Modafinil—Hepatic function abnormal—Adefovir Dipivoxil—hepatitis B	0.0111	0.0129	CcSEcCtD
Modafinil—Influenza like illness—Telbivudine—hepatitis B	0.0109	0.0127	CcSEcCtD
Modafinil—Anaphylactoid reaction—Entecavir—hepatitis B	0.0103	0.0119	CcSEcCtD
Modafinil—Abdominal pain upper—Entecavir—hepatitis B	0.00909	0.0105	CcSEcCtD
Modafinil—Amblyopia—Lamivudine—hepatitis B	0.00822	0.00954	CcSEcCtD
Modafinil—Migraine—Telbivudine—hepatitis B	0.00804	0.00934	CcSEcCtD
Modafinil—Hyperglycaemia—Entecavir—hepatitis B	0.00776	0.00901	CcSEcCtD
Modafinil—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00759	0.00881	CcSEcCtD
Modafinil—Abdominal pain upper—Telbivudine—hepatitis B	0.00746	0.00867	CcSEcCtD
Modafinil—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00736	0.00854	CcSEcCtD
Modafinil—Haematuria—Entecavir—hepatitis B	0.00731	0.00849	CcSEcCtD
Modafinil—Vasodilation procedure—Lamivudine—hepatitis B	0.00722	0.00838	CcSEcCtD
Modafinil—Vasodilation—Lamivudine—hepatitis B	0.00722	0.00838	CcSEcCtD
Modafinil—Muscular weakness—Telbivudine—hepatitis B	0.00721	0.00837	CcSEcCtD
Modafinil—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00713	0.00828	CcSEcCtD
Modafinil—Influenza—Telbivudine—hepatitis B	0.00706	0.0082	CcSEcCtD
Modafinil—Viral infection—Lamivudine—hepatitis B	0.00702	0.00816	CcSEcCtD
Modafinil—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00702	0.00815	CcSEcCtD
Modafinil—Oedema peripheral—Entecavir—hepatitis B	0.00678	0.00787	CcSEcCtD
Modafinil—Hearing impaired—Lamivudine—hepatitis B	0.00666	0.00774	CcSEcCtD
Modafinil—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00666	0.00774	CcSEcCtD
Modafinil—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00663	0.0077	CcSEcCtD
Modafinil—CYP2B6—Nicotine Metabolism—CYP2A6—hepatitis B	0.00662	0.0567	CbGpPWpGaD
Modafinil—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.0066	0.00766	CcSEcCtD
Modafinil—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00658	0.00764	CcSEcCtD
Modafinil—Muscle twitching—Lamivudine—hepatitis B	0.00646	0.0075	CcSEcCtD
Modafinil—Immune system disorder—Entecavir—hepatitis B	0.00622	0.00722	CcSEcCtD
Modafinil—Mental disorder—Entecavir—hepatitis B	0.00603	0.007	CcSEcCtD
Modafinil—Malnutrition—Entecavir—hepatitis B	0.00599	0.00696	CcSEcCtD
Modafinil—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00584	0.00679	CcSEcCtD
Modafinil—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00576	0.00669	CcSEcCtD
Modafinil—Urine output increased—Lamivudine—hepatitis B	0.00574	0.00666	CcSEcCtD
Modafinil—Mouth ulceration—Lamivudine—hepatitis B	0.00574	0.00666	CcSEcCtD
Modafinil—Back pain—Adefovir Dipivoxil—hepatitis B	0.00565	0.00656	CcSEcCtD
Modafinil—Pharyngitis—Telbivudine—hepatitis B	0.00561	0.00652	CcSEcCtD
Modafinil—Connective tissue disorder—Telbivudine—hepatitis B	0.00556	0.00645	CcSEcCtD
Modafinil—Anaemia—Adefovir Dipivoxil—hepatitis B	0.0054	0.00627	CcSEcCtD
Modafinil—Polyuria—Lamivudine—hepatitis B	0.00524	0.00609	CcSEcCtD
Modafinil—Gastroenteritis—Lamivudine—hepatitis B	0.0052	0.00603	CcSEcCtD
Modafinil—Cough—Adefovir Dipivoxil—hepatitis B	0.0051	0.00592	CcSEcCtD
Modafinil—Mediastinal disorder—Telbivudine—hepatitis B	0.00509	0.00592	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00507	0.00588	CcSEcCtD
Modafinil—Injury—Lamivudine—hepatitis B	0.00501	0.00582	CcSEcCtD
Modafinil—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00498	0.00578	CcSEcCtD
Modafinil—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00498	0.00578	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00494	0.00574	CcSEcCtD
Modafinil—Malnutrition—Telbivudine—hepatitis B	0.00492	0.00571	CcSEcCtD
Modafinil—Anaphylactic shock—Entecavir—hepatitis B	0.00489	0.00568	CcSEcCtD
Modafinil—Infection—Entecavir—hepatitis B	0.00486	0.00564	CcSEcCtD
Modafinil—Thirst—Lamivudine—hepatitis B	0.00484	0.00562	CcSEcCtD
Modafinil—Dysgeusia—Telbivudine—hepatitis B	0.00482	0.0056	CcSEcCtD
Modafinil—Nervous system disorder—Entecavir—hepatitis B	0.00479	0.00557	CcSEcCtD
Modafinil—SLC6A3—Alpha-synuclein signaling—UBE2L3—hepatitis B	0.00477	0.0408	CbGpPWpGaD
Modafinil—Back pain—Telbivudine—hepatitis B	0.00476	0.00553	CcSEcCtD
Modafinil—Skin disorder—Entecavir—hepatitis B	0.00475	0.00551	CcSEcCtD
Modafinil—Muscle spasms—Telbivudine—hepatitis B	0.00473	0.00549	CcSEcCtD
Modafinil—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00468	0.00543	CcSEcCtD
Modafinil—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00463	0.00538	CcSEcCtD
Modafinil—Ill-defined disorder—Telbivudine—hepatitis B	0.00457	0.0053	CcSEcCtD
Modafinil—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00455	0.00528	CcSEcCtD
Modafinil—Migraine—Lamivudine—hepatitis B	0.00453	0.00526	CcSEcCtD
Modafinil—Affect lability—Lamivudine—hepatitis B	0.00453	0.00526	CcSEcCtD
Modafinil—Malaise—Telbivudine—hepatitis B	0.00444	0.00515	CcSEcCtD
Modafinil—Insomnia—Entecavir—hepatitis B	0.00442	0.00513	CcSEcCtD
Modafinil—Mood swings—Lamivudine—hepatitis B	0.00436	0.00507	CcSEcCtD
Modafinil—Somnolence—Entecavir—hepatitis B	0.00435	0.00505	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00435	0.00505	CcSEcCtD
Modafinil—Dyspepsia—Entecavir—hepatitis B	0.0043	0.005	CcSEcCtD
Modafinil—Cough—Telbivudine—hepatitis B	0.00429	0.00499	CcSEcCtD
Modafinil—CYP3A5—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.00425	0.0364	CbGpPWpGaD
Modafinil—Gastrointestinal disorder—Entecavir—hepatitis B	0.00422	0.0049	CcSEcCtD
Modafinil—Fatigue—Entecavir—hepatitis B	0.00422	0.00489	CcSEcCtD
Modafinil—Abdominal pain upper—Lamivudine—hepatitis B	0.00421	0.00488	CcSEcCtD
Modafinil—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.0042	0.00488	CcSEcCtD
Modafinil—Myalgia—Telbivudine—hepatitis B	0.00419	0.00486	CcSEcCtD
Modafinil—Arthralgia—Telbivudine—hepatitis B	0.00419	0.00486	CcSEcCtD
Modafinil—Chest pain—Telbivudine—hepatitis B	0.00419	0.00486	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00416	0.00483	CcSEcCtD
Modafinil—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00415	0.00482	CcSEcCtD
Modafinil—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00415	0.00482	CcSEcCtD
Modafinil—Discomfort—Telbivudine—hepatitis B	0.00414	0.00481	CcSEcCtD
Modafinil—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00412	0.00478	CcSEcCtD
Modafinil—CYP2B6—CYP2E1 reactions—CYP2A6—hepatitis B	0.00408	0.0349	CbGpPWpGaD
Modafinil—Muscular weakness—Lamivudine—hepatitis B	0.00406	0.00472	CcSEcCtD
Modafinil—SLC6A3—Parkinsons Disease Pathway—UBE2L3—hepatitis B	0.00405	0.0347	CbGpPWpGaD
Modafinil—Gastrointestinal pain—Entecavir—hepatitis B	0.004	0.00464	CcSEcCtD
Modafinil—Influenza—Lamivudine—hepatitis B	0.00398	0.00462	CcSEcCtD
Modafinil—Nervous system disorder—Telbivudine—hepatitis B	0.00394	0.00457	CcSEcCtD
Modafinil—Skin disorder—Telbivudine—hepatitis B	0.0039	0.00453	CcSEcCtD
Modafinil—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.0039	0.00453	CcSEcCtD
Modafinil—Abdominal pain—Entecavir—hepatitis B	0.00386	0.00449	CcSEcCtD
Modafinil—Body temperature increased—Entecavir—hepatitis B	0.00386	0.00449	CcSEcCtD
Modafinil—Bronchitis—Lamivudine—hepatitis B	0.00383	0.00444	CcSEcCtD
Modafinil—Pancytopenia—Lamivudine—hepatitis B	0.00378	0.00439	CcSEcCtD
Modafinil—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00377	0.00438	CcSEcCtD
Modafinil—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00377	0.00438	CcSEcCtD
Modafinil—Pollakiuria—Lamivudine—hepatitis B	0.00368	0.00427	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00366	0.00425	CcSEcCtD
Modafinil—Insomnia—Telbivudine—hepatitis B	0.00363	0.00422	CcSEcCtD
Modafinil—Paraesthesia—Telbivudine—hepatitis B	0.00361	0.00419	CcSEcCtD
Modafinil—Hyperglycaemia—Lamivudine—hepatitis B	0.00359	0.00417	CcSEcCtD
Modafinil—Depression—Lamivudine—hepatitis B	0.00354	0.00411	CcSEcCtD
Modafinil—Dyspepsia—Telbivudine—hepatitis B	0.00354	0.00411	CcSEcCtD
Modafinil—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00352	0.00409	CcSEcCtD
Modafinil—Asthenia—Entecavir—hepatitis B	0.00351	0.00407	CcSEcCtD
Modafinil—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00347	0.00403	CcSEcCtD
Modafinil—Fatigue—Telbivudine—hepatitis B	0.00346	0.00402	CcSEcCtD
Modafinil—Stomatitis—Lamivudine—hepatitis B	0.00346	0.00402	CcSEcCtD
Modafinil—Pain—Telbivudine—hepatitis B	0.00343	0.00399	CcSEcCtD
Modafinil—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00342	0.00397	CcSEcCtD
Modafinil—Sweating—Lamivudine—hepatitis B	0.0034	0.00395	CcSEcCtD
Modafinil—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00337	0.00392	CcSEcCtD
Modafinil—Epistaxis—Lamivudine—hepatitis B	0.00335	0.00389	CcSEcCtD
Modafinil—Diarrhoea—Entecavir—hepatitis B	0.00335	0.00388	CcSEcCtD
Modafinil—Sinusitis—Lamivudine—hepatitis B	0.00333	0.00387	CcSEcCtD
Modafinil—Agranulocytosis—Lamivudine—hepatitis B	0.00331	0.00385	CcSEcCtD
Modafinil—Feeling abnormal—Telbivudine—hepatitis B	0.00331	0.00384	CcSEcCtD
Modafinil—Gastrointestinal pain—Telbivudine—hepatitis B	0.00328	0.00381	CcSEcCtD
Modafinil—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00326	0.00379	CcSEcCtD
Modafinil—Dizziness—Entecavir—hepatitis B	0.00323	0.00375	CcSEcCtD
Modafinil—CYP1A2—Estrogen Receptor Pathway—NR0B2—hepatitis B	0.00322	0.0276	CbGpPWpGaD
Modafinil—Rhinitis—Lamivudine—hepatitis B	0.00319	0.00371	CcSEcCtD
Modafinil—Body temperature increased—Telbivudine—hepatitis B	0.00318	0.00369	CcSEcCtD
Modafinil—Abdominal pain—Telbivudine—hepatitis B	0.00318	0.00369	CcSEcCtD
Modafinil—Pharyngitis—Lamivudine—hepatitis B	0.00316	0.00367	CcSEcCtD
Modafinil—Connective tissue disorder—Lamivudine—hepatitis B	0.00313	0.00364	CcSEcCtD
Modafinil—Vomiting—Entecavir—hepatitis B	0.00311	0.00361	CcSEcCtD
Modafinil—Rash—Entecavir—hepatitis B	0.00308	0.00358	CcSEcCtD
Modafinil—CYP2C19—CYP2E1 reactions—CYP2A6—hepatitis B	0.00308	0.0264	CbGpPWpGaD
Modafinil—Dermatitis—Entecavir—hepatitis B	0.00308	0.00358	CcSEcCtD
Modafinil—Headache—Entecavir—hepatitis B	0.00306	0.00356	CcSEcCtD
Modafinil—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00303	0.00352	CcSEcCtD
Modafinil—Erythema multiforme—Lamivudine—hepatitis B	0.00301	0.0035	CcSEcCtD
Modafinil—Rash—Adefovir Dipivoxil—hepatitis B	0.00301	0.00349	CcSEcCtD
Modafinil—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.003	0.00349	CcSEcCtD
Modafinil—Headache—Adefovir Dipivoxil—hepatitis B	0.00299	0.00347	CcSEcCtD
Modafinil—Nausea—Entecavir—hepatitis B	0.0029	0.00337	CcSEcCtD
Modafinil—Asthenia—Telbivudine—hepatitis B	0.00288	0.00335	CcSEcCtD
Modafinil—Immune system disorder—Lamivudine—hepatitis B	0.00288	0.00334	CcSEcCtD
Modafinil—Mediastinal disorder—Lamivudine—hepatitis B	0.00287	0.00333	CcSEcCtD
Modafinil—Chills—Lamivudine—hepatitis B	0.00286	0.00332	CcSEcCtD
Modafinil—Pruritus—Telbivudine—hepatitis B	0.00284	0.0033	CcSEcCtD
Modafinil—Nausea—Adefovir Dipivoxil—hepatitis B	0.00283	0.00329	CcSEcCtD
Modafinil—CYP2C9—CYP2E1 reactions—CYP2A6—hepatitis B	0.00281	0.024	CbGpPWpGaD
Modafinil—Malnutrition—Lamivudine—hepatitis B	0.00277	0.00322	CcSEcCtD
Modafinil—Diarrhoea—Telbivudine—hepatitis B	0.00275	0.00319	CcSEcCtD
Modafinil—Flatulence—Lamivudine—hepatitis B	0.00273	0.00317	CcSEcCtD
Modafinil—Tension—Lamivudine—hepatitis B	0.00272	0.00316	CcSEcCtD
Modafinil—Dysgeusia—Lamivudine—hepatitis B	0.00272	0.00315	CcSEcCtD
Modafinil—Nervousness—Lamivudine—hepatitis B	0.00269	0.00313	CcSEcCtD
Modafinil—Back pain—Lamivudine—hepatitis B	0.00268	0.00312	CcSEcCtD
Modafinil—Muscle spasms—Lamivudine—hepatitis B	0.00267	0.0031	CcSEcCtD
Modafinil—Dizziness—Telbivudine—hepatitis B	0.00266	0.00308	CcSEcCtD
Modafinil—Tremor—Lamivudine—hepatitis B	0.0026	0.00302	CcSEcCtD
Modafinil—Ill-defined disorder—Lamivudine—hepatitis B	0.00257	0.00299	CcSEcCtD
Modafinil—Anaemia—Lamivudine—hepatitis B	0.00256	0.00298	CcSEcCtD
Modafinil—CYP1A2—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.00256	0.0219	CbGpPWpGaD
Modafinil—Vomiting—Telbivudine—hepatitis B	0.00255	0.00297	CcSEcCtD
Modafinil—Angioedema—Lamivudine—hepatitis B	0.00253	0.00294	CcSEcCtD
Modafinil—Rash—Telbivudine—hepatitis B	0.00253	0.00294	CcSEcCtD
Modafinil—Dermatitis—Telbivudine—hepatitis B	0.00253	0.00294	CcSEcCtD
Modafinil—CYP2B6—Xenobiotics—CYP2A6—hepatitis B	0.00253	0.0216	CbGpPWpGaD
Modafinil—Headache—Telbivudine—hepatitis B	0.00252	0.00292	CcSEcCtD
Modafinil—Malaise—Lamivudine—hepatitis B	0.0025	0.0029	CcSEcCtD
Modafinil—Vertigo—Lamivudine—hepatitis B	0.00249	0.00289	CcSEcCtD
Modafinil—Syncope—Lamivudine—hepatitis B	0.00249	0.00289	CcSEcCtD
Modafinil—CYP3A5—Xenobiotics—CYP2A6—hepatitis B	0.00247	0.0211	CbGpPWpGaD
Modafinil—Loss of consciousness—Lamivudine—hepatitis B	0.00244	0.00283	CcSEcCtD
Modafinil—Cough—Lamivudine—hepatitis B	0.00242	0.00281	CcSEcCtD
Modafinil—Convulsion—Lamivudine—hepatitis B	0.0024	0.00279	CcSEcCtD
Modafinil—Nausea—Telbivudine—hepatitis B	0.00239	0.00277	CcSEcCtD
Modafinil—CYP3A5—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00238	0.0203	CbGpPWpGaD
Modafinil—Arthralgia—Lamivudine—hepatitis B	0.00236	0.00274	CcSEcCtD
Modafinil—Myalgia—Lamivudine—hepatitis B	0.00236	0.00274	CcSEcCtD
Modafinil—Chest pain—Lamivudine—hepatitis B	0.00236	0.00274	CcSEcCtD
Modafinil—Anxiety—Lamivudine—hepatitis B	0.00235	0.00273	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00234	0.00272	CcSEcCtD
Modafinil—Discomfort—Lamivudine—hepatitis B	0.00233	0.00271	CcSEcCtD
Modafinil—Dry mouth—Lamivudine—hepatitis B	0.00231	0.00268	CcSEcCtD
Modafinil—Confusional state—Lamivudine—hepatitis B	0.00228	0.00265	CcSEcCtD
Modafinil—Anaphylactic shock—Lamivudine—hepatitis B	0.00226	0.00263	CcSEcCtD
Modafinil—Oedema—Lamivudine—hepatitis B	0.00226	0.00263	CcSEcCtD
Modafinil—Infection—Lamivudine—hepatitis B	0.00225	0.00261	CcSEcCtD
Modafinil—Shock—Lamivudine—hepatitis B	0.00223	0.00259	CcSEcCtD
Modafinil—Cinnarizine—CYP2A6—hepatitis B	0.00222	0.209	CrCbGaD
Modafinil—Nervous system disorder—Lamivudine—hepatitis B	0.00222	0.00258	CcSEcCtD
Modafinil—Skin disorder—Lamivudine—hepatitis B	0.0022	0.00255	CcSEcCtD
Modafinil—Hyperhidrosis—Lamivudine—hepatitis B	0.00219	0.00254	CcSEcCtD
Modafinil—Anorexia—Lamivudine—hepatitis B	0.00216	0.00251	CcSEcCtD
Modafinil—Hypotension—Lamivudine—hepatitis B	0.00212	0.00246	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00206	0.00239	CcSEcCtD
Modafinil—Insomnia—Lamivudine—hepatitis B	0.00205	0.00238	CcSEcCtD
Modafinil—Paraesthesia—Lamivudine—hepatitis B	0.00203	0.00236	CcSEcCtD
Modafinil—Dyspnoea—Lamivudine—hepatitis B	0.00202	0.00234	CcSEcCtD
Modafinil—Somnolence—Lamivudine—hepatitis B	0.00201	0.00234	CcSEcCtD
Modafinil—CYP3A5—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.00201	0.0172	CbGpPWpGaD
Modafinil—Dyspepsia—Lamivudine—hepatitis B	0.00199	0.00231	CcSEcCtD
Modafinil—CYP3A4—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.00198	0.0169	CbGpPWpGaD
Modafinil—Decreased appetite—Lamivudine—hepatitis B	0.00197	0.00228	CcSEcCtD
Modafinil—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00195	0.00227	CcSEcCtD
Modafinil—Fatigue—Lamivudine—hepatitis B	0.00195	0.00227	CcSEcCtD
Modafinil—Pain—Lamivudine—hepatitis B	0.00194	0.00225	CcSEcCtD
Modafinil—Constipation—Lamivudine—hepatitis B	0.00194	0.00225	CcSEcCtD
Modafinil—CYP2C19—Xenobiotics—CYP2A6—hepatitis B	0.00191	0.0163	CbGpPWpGaD
Modafinil—Feeling abnormal—Lamivudine—hepatitis B	0.00187	0.00217	CcSEcCtD
Modafinil—Gastrointestinal pain—Lamivudine—hepatitis B	0.00185	0.00215	CcSEcCtD
Modafinil—CYP2C19—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00184	0.0157	CbGpPWpGaD
Modafinil—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—hepatitis B	0.00184	0.0157	CbGpPWpGaD
Modafinil—Urticaria—Lamivudine—hepatitis B	0.0018	0.00209	CcSEcCtD
Modafinil—Fosphenytoin—ALB—hepatitis B	0.0018	0.169	CrCbGaD
Modafinil—Abdominal pain—Lamivudine—hepatitis B	0.00179	0.00208	CcSEcCtD
Modafinil—Body temperature increased—Lamivudine—hepatitis B	0.00179	0.00208	CcSEcCtD
Modafinil—CYP1A2—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.00178	0.0152	CbGpPWpGaD
Modafinil—CYP2C9—Xenobiotics—CYP2A6—hepatitis B	0.00174	0.0149	CbGpPWpGaD
Modafinil—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00174	0.0149	CbGpPWpGaD
Modafinil—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.0017	0.0145	CbGpPWpGaD
Modafinil—CYP2C9—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00168	0.0143	CbGpPWpGaD
Modafinil—Hypersensitivity—Lamivudine—hepatitis B	0.00167	0.00194	CcSEcCtD
Modafinil—Asthenia—Lamivudine—hepatitis B	0.00162	0.00189	CcSEcCtD
Modafinil—Pruritus—Lamivudine—hepatitis B	0.0016	0.00186	CcSEcCtD
Modafinil—Diarrhoea—Lamivudine—hepatitis B	0.00155	0.0018	CcSEcCtD
Modafinil—Dizziness—Lamivudine—hepatitis B	0.0015	0.00174	CcSEcCtD
Modafinil—CYP1A2—Xenobiotics—CYP2A6—hepatitis B	0.00149	0.0127	CbGpPWpGaD
Modafinil—CYP2C19—blood plasma—hepatitis B	0.00144	0.127	CbGeAlD
Modafinil—Vomiting—Lamivudine—hepatitis B	0.00144	0.00167	CcSEcCtD
Modafinil—CYP1A2—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00143	0.0122	CbGpPWpGaD
Modafinil—Fenoprofen—ALB—hepatitis B	0.00143	0.135	CrCbGaD
Modafinil—Rash—Lamivudine—hepatitis B	0.00143	0.00166	CcSEcCtD
Modafinil—Dermatitis—Lamivudine—hepatitis B	0.00143	0.00166	CcSEcCtD
Modafinil—Headache—Lamivudine—hepatitis B	0.00142	0.00165	CcSEcCtD
Modafinil—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.00137	0.0118	CbGpPWpGaD
Modafinil—Nausea—Lamivudine—hepatitis B	0.00134	0.00156	CcSEcCtD
Modafinil—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00131	0.0112	CbGpPWpGaD
Modafinil—ADRA1B—AMPK Signaling—HNF4A—hepatitis B	0.00129	0.011	CbGpPWpGaD
Modafinil—SLC6A3—NRF2 pathway—GGT2—hepatitis B	0.00126	0.0108	CbGpPWpGaD
Modafinil—Phenprocoumon—ALB—hepatitis B	0.00123	0.116	CrCbGaD
Modafinil—CYP1A2—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.00121	0.0104	CbGpPWpGaD
Modafinil—Oxcarbazepine—ALB—hepatitis B	0.0012	0.113	CrCbGaD
Modafinil—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.0012	0.0102	CbGpPWpGaD
Modafinil—CYP1A2—blood plasma—hepatitis B	0.00118	0.104	CbGeAlD
Modafinil—CYP3A4—Xenobiotics—CYP2A6—hepatitis B	0.00115	0.00983	CbGpPWpGaD
Modafinil—CYP3A5—blood plasma—hepatitis B	0.00114	0.1	CbGeAlD
Modafinil—CYP2B6—blood plasma—hepatitis B	0.00113	0.0996	CbGeAlD
Modafinil—CYP2C9—blood plasma—hepatitis B	0.00112	0.0986	CbGeAlD
Modafinil—CYP3A4—Tamoxifen metabolism—CYP2A6—hepatitis B	0.0011	0.00945	CbGpPWpGaD
Modafinil—Warfarin—ALB—hepatitis B	0.00109	0.103	CrCbGaD
Modafinil—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.00105	0.00898	CbGpPWpGaD
Modafinil—CYP2B6—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.00104	0.00886	CbGpPWpGaD
Modafinil—SLC6A3—Neuronal System—KCNH1—hepatitis B	0.00103	0.00885	CbGpPWpGaD
Modafinil—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.00103	0.00878	CbGpPWpGaD
Modafinil—CYP3A5—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.00101	0.00866	CbGpPWpGaD
Modafinil—CYP3A4—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.000934	0.008	CbGpPWpGaD
Modafinil—CYP3A4—blood plasma—hepatitis B	0.000852	0.0752	CbGeAlD
Modafinil—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000851	0.00728	CbGpPWpGaD
Modafinil—Ketoprofen—ALB—hepatitis B	0.000843	0.0795	CrCbGaD
Modafinil—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000832	0.00712	CbGpPWpGaD
Modafinil—Phenytoin—ALB—hepatitis B	0.000794	0.0748	CrCbGaD
Modafinil—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000793	0.00679	CbGpPWpGaD
Modafinil—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000789	0.00675	CbGpPWpGaD
Modafinil—CYP2C19—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000783	0.0067	CbGpPWpGaD
Modafinil—CYP2B6—Metapathway biotransformation—AKR1B1—hepatitis B	0.000768	0.00657	CbGpPWpGaD
Modafinil—SLC6A3—NRF2 pathway—CYP2A6—hepatitis B	0.000765	0.00654	CbGpPWpGaD
Modafinil—CYP1A2—Phase II conjugation—GGT2—hepatitis B	0.000751	0.00643	CbGpPWpGaD
Modafinil—CYP3A5—Metapathway biotransformation—AKR1B1—hepatitis B	0.00075	0.00642	CbGpPWpGaD
Modafinil—CYP2B6—Biological oxidations—GGT2—hepatitis B	0.000746	0.00638	CbGpPWpGaD
Modafinil—CYP3A5—Biological oxidations—GGT2—hepatitis B	0.000729	0.00624	CbGpPWpGaD
Modafinil—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000723	0.00619	CbGpPWpGaD
Modafinil—CYP2C19—Arachidonic acid metabolism—GGT1—hepatitis B	0.000717	0.00613	CbGpPWpGaD
Modafinil—CYP2C9—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000714	0.00611	CbGpPWpGaD
Modafinil—SLC6A3—Dopaminergic Neurogenesis—TGFB1—hepatitis B	0.000712	0.00609	CbGpPWpGaD
Modafinil—CYP2C9—Arachidonic acid metabolism—GGT1—hepatitis B	0.000653	0.00559	CbGpPWpGaD
Modafinil—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000643	0.0055	CbGpPWpGaD
Modafinil—SLC6A3—Monoamine Transport—TNF—hepatitis B	0.000632	0.0054	CbGpPWpGaD
Modafinil—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000618	0.00529	CbGpPWpGaD
Modafinil—CYP1A2—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.00061	0.00522	CbGpPWpGaD
Modafinil—SLC6A3—NRF2 pathway—GGT1—hepatitis B	0.000597	0.00511	CbGpPWpGaD
Modafinil—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000586	0.00502	CbGpPWpGaD
Modafinil—CYP2C19—Metapathway biotransformation—AKR1B1—hepatitis B	0.00058	0.00496	CbGpPWpGaD
Modafinil—CYP2C19—Biological oxidations—GGT2—hepatitis B	0.000564	0.00482	CbGpPWpGaD
Modafinil—CYP1A2—Arachidonic acid metabolism—GGT1—hepatitis B	0.000558	0.00478	CbGpPWpGaD
Modafinil—CYP2C9—Metapathway biotransformation—AKR1B1—hepatitis B	0.000529	0.00453	CbGpPWpGaD
Modafinil—CYP2C19—blood—hepatitis B	0.000528	0.0466	CbGeAlD
Modafinil—CYP2C9—Biological oxidations—GGT2—hepatitis B	0.000514	0.0044	CbGpPWpGaD
Modafinil—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000501	0.00429	CbGpPWpGaD
Modafinil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000477	0.00408	CbGpPWpGaD
Modafinil—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000471	0.00403	CbGpPWpGaD
Modafinil—CYP2B6—Biological oxidations—CYP2A6—hepatitis B	0.000452	0.00387	CbGpPWpGaD
Modafinil—CYP1A2—Metapathway biotransformation—AKR1B1—hepatitis B	0.000452	0.00387	CbGpPWpGaD
Modafinil—CYP2C19—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000447	0.00383	CbGpPWpGaD
Modafinil—CYP3A5—Biological oxidations—CYP2A6—hepatitis B	0.000442	0.00378	CbGpPWpGaD
Modafinil—CYP1A2—Biological oxidations—GGT2—hepatitis B	0.000439	0.00376	CbGpPWpGaD
Modafinil—CYP1A2—blood—hepatitis B	0.000431	0.0381	CbGeAlD
Modafinil—CYP3A5—blood—hepatitis B	0.000416	0.0367	CbGeAlD
Modafinil—CYP2B6—blood—hepatitis B	0.000413	0.0365	CbGeAlD
Modafinil—CYP2C19—liver—hepatitis B	0.000413	0.0365	CbGeAlD
Modafinil—CYP2C9—blood—hepatitis B	0.000409	0.0361	CbGeAlD
Modafinil—ADRA1B—LPA receptor mediated events—NFKB1—hepatitis B	0.000406	0.00348	CbGpPWpGaD
Modafinil—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000387	0.00331	CbGpPWpGaD
Modafinil—ADRA1B—AMPK Signaling—CDKN1A—hepatitis B	0.000385	0.0033	CbGpPWpGaD
Modafinil—CYP1A2—Phase II conjugation—GGT1—hepatitis B	0.000355	0.00304	CbGpPWpGaD
Modafinil—CYP2B6—Biological oxidations—GGT1—hepatitis B	0.000353	0.00302	CbGpPWpGaD
Modafinil—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	0.000349	0.00298	CbGpPWpGaD
Modafinil—CYP1A2—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000349	0.00298	CbGpPWpGaD
Modafinil—CYP3A5—Biological oxidations—GGT1—hepatitis B	0.000345	0.00295	CbGpPWpGaD
Modafinil—CYP2C19—Biological oxidations—CYP2A6—hepatitis B	0.000342	0.00292	CbGpPWpGaD
Modafinil—CYP3A4—Biological oxidations—GGT2—hepatitis B	0.000339	0.0029	CbGpPWpGaD
Modafinil—CYP1A2—liver—hepatitis B	0.000337	0.0298	CbGeAlD
Modafinil—CYP3A5—liver—hepatitis B	0.000325	0.0287	CbGeAlD
Modafinil—CYP2B6—liver—hepatitis B	0.000323	0.0285	CbGeAlD
Modafinil—CYP2C9—liver—hepatitis B	0.00032	0.0283	CbGeAlD
Modafinil—CYP3A4—blood—hepatitis B	0.000312	0.0276	CbGeAlD
Modafinil—CYP2C9—Biological oxidations—CYP2A6—hepatitis B	0.000311	0.00267	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—hepatitis B	0.00029	0.00248	CbGpPWpGaD
Modafinil—ADRA1B—G alpha (q) signalling events—F2—hepatitis B	0.000273	0.00234	CbGpPWpGaD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.000272	0.00233	CbGpPWpGaD
Modafinil—CYP2C19—Biological oxidations—GGT1—hepatitis B	0.000267	0.00228	CbGpPWpGaD
Modafinil—CYP1A2—Biological oxidations—CYP2A6—hepatitis B	0.000266	0.00228	CbGpPWpGaD
Modafinil—ADRA1B—AMPK Signaling—TP53—hepatitis B	0.000262	0.00224	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—hepatitis B	0.000257	0.0022	CbGpPWpGaD
Modafinil—ADRA1B—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	0.000246	0.00211	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—F2—hepatitis B	0.000244	0.00209	CbGpPWpGaD
Modafinil—CYP3A4—liver—hepatitis B	0.000244	0.0215	CbGeAlD
Modafinil—CYP2C9—Biological oxidations—GGT1—hepatitis B	0.000243	0.00208	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—hepatitis B	0.000243	0.00208	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—hepatitis B	0.000241	0.00206	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000226	0.00193	CbGpPWpGaD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000211	0.0018	CbGpPWpGaD
Modafinil—CYP1A2—Biological oxidations—GGT1—hepatitis B	0.000208	0.00178	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—CXCL10—hepatitis B	0.000207	0.00177	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000206	0.00176	CbGpPWpGaD
Modafinil—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	0.000205	0.00176	CbGpPWpGaD
Modafinil—SLC6A3—NRF2 pathway—TGFB1—hepatitis B	0.000201	0.00172	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—hepatitis B	0.000201	0.00172	CbGpPWpGaD
Modafinil—SLC6A3—SLC-mediated transmembrane transport—ALB—hepatitis B	0.0002	0.00171	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—TNF—hepatitis B	0.000187	0.0016	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—hepatitis B	0.000187	0.0016	CbGpPWpGaD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000181	0.00155	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000176	0.00151	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—CCR5—hepatitis B	0.000161	0.00137	CbGpPWpGaD
Modafinil—CYP3A4—Biological oxidations—GGT1—hepatitis B	0.00016	0.00137	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SAG—hepatitis B	0.000159	0.00136	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—RIT2—hepatitis B	0.000159	0.00136	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—F2—hepatitis B	0.000138	0.00118	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—AKR1B1—hepatitis B	0.000133	0.00114	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—AKR1B1—hepatitis B	0.00013	0.00111	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GGT2—hepatitis B	0.000128	0.00109	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GGT2—hepatitis B	0.000125	0.00107	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—CXCL10—hepatitis B	0.000117	0.001	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—CXCL10—hepatitis B	0.000106	0.000909	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000102	0.000876	CbGpPWpGaD
Modafinil—SLC6A3—Transmembrane transport of small molecules—ALB—hepatitis B	0.000102	0.00087	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—AKR1B1—hepatitis B	0.000101	0.000861	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	9.67e-05	0.000828	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GGT2—hepatitis B	9.64e-05	0.000825	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	9.34e-05	0.000799	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—AKR1B1—hepatitis B	9.17e-05	0.000785	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—CCR5—hepatitis B	9.08e-05	0.000777	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GGT2—hepatitis B	8.79e-05	0.000752	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—CCR5—hepatitis B	8.24e-05	0.000705	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	7.98e-05	0.000683	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—AKR1B1—hepatitis B	7.84e-05	0.000671	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—F2—hepatitis B	7.79e-05	0.000666	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYP2A6—hepatitis B	7.73e-05	0.000661	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP2A6—hepatitis B	7.56e-05	0.000647	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GGT2—hepatitis B	7.51e-05	0.000643	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—F2—hepatitis B	7.07e-05	0.000605	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GOT2—hepatitis B	6.99e-05	0.000598	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GOT2—hepatitis B	6.83e-05	0.000585	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CXCL10—hepatitis B	6.28e-05	0.000537	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—AKR1B1—hepatitis B	6.05e-05	0.000517	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GGT1—hepatitis B	6.03e-05	0.000516	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GOT1—hepatitis B	6.03e-05	0.000516	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GGT1—hepatitis B	5.9e-05	0.000505	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GOT1—hepatitis B	5.9e-05	0.000505	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP2A6—hepatitis B	5.84e-05	0.0005	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GGT2—hepatitis B	5.8e-05	0.000496	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hepatitis B	5.45e-05	0.000466	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP2A6—hepatitis B	5.33e-05	0.000456	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GOT2—hepatitis B	5.28e-05	0.000452	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—IL2—hepatitis B	5.24e-05	0.000449	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	4.97e-05	0.000425	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CCR5—hepatitis B	4.87e-05	0.000417	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GOT2—hepatitis B	4.82e-05	0.000412	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—IL2—hepatitis B	4.76e-05	0.000407	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GGT1—hepatitis B	4.56e-05	0.00039	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GOT1—hepatitis B	4.56e-05	0.00039	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP2A6—hepatitis B	4.55e-05	0.000389	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	4.24e-05	0.000363	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—F2—hepatitis B	4.18e-05	0.000357	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GOT1—hepatitis B	4.16e-05	0.000356	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GGT1—hepatitis B	4.16e-05	0.000356	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	4.16e-05	0.000356	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GOT2—hepatitis B	4.12e-05	0.000352	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	3.79e-05	0.000324	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GOT1—hepatitis B	3.55e-05	0.000304	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GGT1—hepatitis B	3.55e-05	0.000304	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP2A6—hepatitis B	3.51e-05	0.000301	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	3.24e-05	0.000277	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ALB—hepatitis B	3.21e-05	0.000275	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GOT2—hepatitis B	3.18e-05	0.000272	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ALB—hepatitis B	3.14e-05	0.000268	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IL2—hepatitis B	2.81e-05	0.000241	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—IL6—hepatitis B	2.8e-05	0.000239	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GGT1—hepatitis B	2.74e-05	0.000235	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GOT1—hepatitis B	2.74e-05	0.000235	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CTNNB1—hepatitis B	2.72e-05	0.000232	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CDKN1A—hepatitis B	2.65e-05	0.000227	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PTEN—hepatitis B	2.65e-05	0.000226	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NFKB1—hepatitis B	2.63e-05	0.000225	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PTEN—hepatitis B	2.45e-05	0.00021	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ALB—hepatitis B	2.43e-05	0.000208	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PTEN—hepatitis B	2.39e-05	0.000205	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ALB—hepatitis B	2.21e-05	0.000189	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TGFB1—hepatitis B	2.19e-05	0.000188	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ALB—hepatitis B	1.89e-05	0.000162	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PTEN—hepatitis B	1.85e-05	0.000158	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TP53—hepatitis B	1.81e-05	0.000155	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PTEN—hepatitis B	1.69e-05	0.000144	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IL6—hepatitis B	1.65e-05	0.000141	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ALB—hepatitis B	1.46e-05	0.000125	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PTEN—hepatitis B	1.44e-05	0.000123	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PTEN—hepatitis B	1.11e-05	9.52e-05	CbGpPWpGaD
